There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet ...

点击蓝字关注我们【导读】癌症疫苗面临的一个基本挑战，是如何产生对肿瘤抗原具有特异性的长效功能性T细胞。在这项研究中，团队发现针对体细胞突变衍生的新抗原的mRNA脂质体疫苗，可以解决胰腺导管腺癌（PDAC）的这一难题。2025年2月19日，美国纪念斯隆 ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

在癌症治疗的战场上，疫苗一直被寄予厚望，它就像一位英勇的战士，肩负着对抗癌症的重任。然而，现实却给这位战士设置了重重障碍。其中一个最棘手的问题就是，如何让癌症疫苗产生长期存活且功能强大的 T 细胞（一种在免疫系统中发挥关键作用的白细胞，能识别和攻击异常细胞），而且这些 T 细胞还得精准地针对肿瘤抗原。这就好比要训练出一批神枪手，不仅要百发百中，还得能长时间坚守岗位。

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease post-surgery. MSK's phase 1 cli ...